ALPHAPORT.AI
🇺🇸AGILENT TECHNOLOGIES, INC.A
USDUSD
SectorHealth CareIndustryLife Sciences Tools and Services
Management
Padraig McDonnell
CEO

Company information

Ticker
A
Country
United States
Sector
Health Care
Industry
Life Sciences Tools and Services

AGILENT TECHNOLOGIES Business Summary

Agilent Technologies, Inc. (A) operates a diversified life sciences and diagnostics business model, generating revenue through the sale of analytical instruments, consumables, software, and professional services. As of early 2026, the company’s operations are organized into three primary segments: Life Sciences and Diagnostics Markets (LDG), which provides workflow solutions for pharmaceutical and clinical customers; Applied Markets (AMG), serving the environmental, food, and industrial sectors; and Agilent CrossLab (ACG), a high-margin services and consumables division that drives over 55% of total revenue through recurring sales. Agilent maintains a premium position in the global analytical instrumentation market, distinguished by its "Ignite" operating model and a focus on high-growth areas like digital pathology and cell analysis. It competes directly with industry giants such as Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, and Shimadzu Corporation, typically positioning itself as a leader in product quality and customer service within the mid-to-high-tier laboratory technology space. Originally established in 1999 as a spin-off of Hewlett-Packard’s test and measurement business, Agilent is currently led by President and CEO Padraig McDonnell, a company veteran who joined the HP/Agilent organization in 1998 and previously served as Chief Commercial Officer. The executive leadership team includes Senior Vice President and CFO Adam S. Elinoff and Chief Technology Officer August Specht, who oversees the firm’s R&D and innovation pipeline. The company’s strategic direction is further guided by a high-profile Board of Directors chaired by Boon Hwee Koh, featuring notable members such as Pascal Soriot (CEO of AstraZeneca) and Judy Gawlik Brown. This leadership group emphasizes operational excellence and disciplined capital deployment, recently overseeing the strategic acquisition of BIOVECTRA to expand Agilent’s footprint in the contract development and manufacturing (CDMO) sector.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.